Search research articles
Contact Us
Filters
Showing results (11-20 of 70) with videos related to
Page
of 7
Sort By:
Nature Reviews. Clinical Oncology
|
April 18, 2012
Patient-derived tumour xenografts as models for oncology drug development
John J Tentler, Aik Choon Tan, Colin D Weekes, et al.
Plos One
|
March 23, 2013
Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancer
Erica L Bradshaw-Pierce, Todd M Pitts, Gillian Kulikowski, et al.
Investigational New Drugs
|
March 15, 2012
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
A Dasari, L Gore, W A Messersmith, et al.
Neoplasia (New York, N.Y.)
|
September 7, 2012
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer
Colin D Weekes, Dongweon Song, John Arcaroli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2010
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer
Jeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2012
Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer
Wen Wee Ma, Wells A Messersmith, Grace K Dy, et al.
Oncotarget
|
January 1, 2017
CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming
Agnieszka A Kendrick, Johnathon Schafer, Monika Dzieciatkowska, et al.
Cancer
|
November 8, 2012
Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
Manon Buijs, Diane K Reyes, Timothy M Pawlik, et al.
Investigational New Drugs
|
March 8, 2014
A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors
Colin D Weekes, Muralidhar Beeram, Anthony W Tolcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen
Colin D Weekes, Julie M Vose, Jim C Lynch, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 70) with videos related to
Sort By:
Page
of 7
Nature Reviews. Clinical Oncology
|
April 18, 2012
Patient-derived tumour xenografts as models for oncology drug development
John J Tentler, Aik Choon Tan, Colin D Weekes, et al.
Plos One
|
March 23, 2013
Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancer
Erica L Bradshaw-Pierce, Todd M Pitts, Gillian Kulikowski, et al.
Investigational New Drugs
|
March 15, 2012
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
A Dasari, L Gore, W A Messersmith, et al.
Neoplasia (New York, N.Y.)
|
September 7, 2012
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer
Colin D Weekes, Dongweon Song, John Arcaroli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2010
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer
Jeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2012
Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer
Wen Wee Ma, Wells A Messersmith, Grace K Dy, et al.
Oncotarget
|
January 1, 2017
CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming
Agnieszka A Kendrick, Johnathon Schafer, Monika Dzieciatkowska, et al.
Cancer
|
November 8, 2012
Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
Manon Buijs, Diane K Reyes, Timothy M Pawlik, et al.
Investigational New Drugs
|
March 8, 2014
A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors
Colin D Weekes, Muralidhar Beeram, Anthony W Tolcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen
Colin D Weekes, Julie M Vose, Jim C Lynch, et al.
Page
of 7